Jul 8 |
Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
|
Jul 8 |
Nasdaq Rises to New High in Midday Monday Trading Ahead of This Week's Powell Testimony, Inflation Report
|
Jul 8 |
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
|
Jul 8 |
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
|
Jul 8 |
Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal
|
Jul 8 |
Wall Street Lunch: Merger Monday In All Its Glory
|
Jul 8 |
Biden, Boeing plea deal, French markets: Morning Brief
|
Jul 8 |
Top Midday Stories: Boeing Reaches Settlement with DOJ Over Fatal 737 Max Crashes; Eli Lilly Acquires Morphic for $3.2 Billion; Paramount to Merge with Skydance
|
Jul 8 |
Eli Lilly to acquire Morphic in $3.2B deal
|
Jul 8 |
Eli Lilly Buys Morphic for $3.2B
|